disclaimer
This page is not intended for US audiencesgo to us website continue
If you have questions about MagVenture products or services, you are always welcome to call our main number at +1888 624 7764 or contact one of our departments:
We answer all questions regarding quotes, ongoing orders and return orders.
We deal with inquiries regarding service on your products as well as purchase of spare parts.
We answer all questions regarding the selection, use and setup of MagVenture products.
FDA has cleared MagVenture TMS Therapy for adjunct treatment of Obsessive-Compulsive Disorder.
FDA has cleared MagVenture TMS Therapy® for adjunct treatment of Obsessive-Compulsive Disorder (OCD). This marks MagVenture's second indication in the US . MagVenture TMS Therapy is already FDA cleared for the treatment of major depressive disorder.
MagVenture TMS Therapy is an adjunct treatment to existing OCD therapies which may involve pharmaceutical and behavioral therapy. It is an out-patient procedure with no systemic side effects. The treatment specifically targets the networks in the brain which are known to be particularly affected by OCD, including the deeper-lying structures.
“We have worked closely with brain researchers for well over 25 years, providing numerous TMS solutions to help advance the field of neuroscience – both basic and applied. Expanding the treatment options to include other indications than major depressive disorder, such as OCD, is one more important step towards helping more adult patients improve their mental health,” says VP of Sales, MagVenture Inc, Kerry Rome.
OCD is a mental health disorder characterized by unreasonable thoughts and fears (obsessions) which lead to repetitive behavior (compulsions). OCD can severely affect one’s daily life and routines and cause distress or even functional impairment. Although pharmaceutical and psychological interventions are available, some OCD patients experience limited results from these and need more therapeutic options.
Transcranial Magnetic Stimulation (TMS) uses magnetic pulses to stimulate a specific area in the brain in order to improve the OCD symptoms. TMS is a well-established, FDA cleared option for people suffering from treatment-resistant Major Depressive Disorder and available throughout the US at numerous psychiatric practices and hospitals. MagVenture TMS Therapy® was FDA cleared for depression in 2015 and the first company to receive FDA clearance for the 3-minute Express TMS® – the shortest TMS treatment currently available.
MagVenture TMS Therapy® FDA clearances: “As an adjunct for the treatment of adult patients suffering from Obsessive-Compulsive Disorder (OCD)” and “Treatment of Major Depressive Disorder in adult patients who have failed to receive satisfactory improvement from prior antidepressant medication in the current episode.”
Do you need help? Let us know how our experts can help you.